Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications plant antitumor agents iii convenient separation tannins other plant constituents
… Decisions From making drug development decisions, to phase III evidence plans, to developing pricing strategies and … is important to understand the balance that patients and other decision makers are willing to strike between treatment … and communicate risk tolerance from patients and other stakeholders to inform regulatory evaluations. As a …
… criteria - Refine responder definitions - Power Phase III and recruit appropriate patients Phase III - Identify subpopulations for market segmentation - …
… Systematic and Other Literature Reviews We design literature reviews to meet … also have the experience to offer guidance and conduct other types of literature reviews that are intended for a … all relevant studies for a meta-analysis To satisfy HTA or other formulary submission requirements Example A study to …
… independent study in collaboration with research firm Plant-A Insights Group. RTI earned four out of five stars, … work-life balance? Newsweek and market-data research firm Plant-A Insights are proud to introduce ‘America’s Greatest …
… conducted in collaboration with market-data research firm Plant-A Insights. “We are thrilled to be honored by Newsweek … responsibilities. Newsweek and market-data research firm Plant-A Insights are proud to introduce America's Greatest … bonus opportunities and a robust recognition program. Other benefits include a competitive range of family …
… Global Value Dossiers and Other Value Communication Materials Your messages need to be … Let us help develop your global value dossiers (GVDs) and other high-impact communication tools to ensure your research … to the market and how it will be positioned relative to other products. Information is presented so that all users …
… strategy. Chart reviews, separately or in combination with other data sources or surveys , can help you understand: …
… during July 2012 to June 2016. The combination of targeted agents bendamustine and rituximab increased to a peak of 31% … but its use had declined sharply by early 2016. Similarly, other rituximab-based combination immunochemotherapies … the frontline therapy for CLL in the US. Additional novel agents are on the horizon for treatment of CLL, and treatment …
… Publication Management and Medical Writing Publications are critical for the dissemination of your … and internal milestones is an integral part of the publications process. We develop a customized timeline for … following best practices. Our publication managers submit publications to journals across the spectrum of scientific …
… and focus groups) with patients, physicians, and other stakeholder Developing and implementing consumer-based … results (e.g., scientific conferences, peer-reviewed publications ) …